45 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote … on executive compensation and any golden parachute payments not previously approved.
We have elected to take advantage of certain of the reduced
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
firm pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in our periodic … reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements … , and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously
S-3
dd3roqo 68iwx
23 Dec 22
Shelf registration
4:16pm
424B4
06nfm7f0u8a3gstha7b
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
k50gng hadgwa1
20 Oct 22
Draft registration statement
12:00am
DEF 14A
cjm6 rgb0v3s8or5zx
25 Apr 22
Definitive proxy
5:28pm
10-K
ylhu6dj
30 Mar 22
Annual report
7:40am
10-Q
4b48uj b4e
17 Nov 21
Quarterly report
5:15pm
424B4
vqc9mwj8a l0uvcxaz
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
EX-10.24
f28e9tac
19 Jul 21
IPO registration
7:02am
S-1
EX-10.25
lkkvmq9193uhffka9
19 Jul 21
IPO registration
7:02am